Janney Montgomery Scott LLC acquired a new stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 5,470 shares of the technology company’s stock, valued at approximately $338,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after buying an additional 900 shares during the period. Barclays PLC bought a new position in shares of Kewaunee Scientific during the third quarter valued at about $121,000. State Street Corp purchased a new stake in shares of Kewaunee Scientific during the third quarter worth about $266,000. Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after purchasing an additional 2,156 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares during the period. Institutional investors own 32.69% of the company’s stock.
Kewaunee Scientific Stock Up 3.4 %
Shares of Kewaunee Scientific stock opened at $66.18 on Tuesday. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $67.55. The company has a market cap of $189.94 million, a P/E ratio of 10.49 and a beta of 0.71. The company’s fifty day simple moving average is $57.20 and its two-hundred day simple moving average is $46.96.
Insider Transactions at Kewaunee Scientific
In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 2,049 shares of the firm’s stock in a transaction that occurred on Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total transaction of $119,231.31. Following the completion of the transaction, the chief financial officer now owns 22,615 shares of the company’s stock, valued at approximately $1,315,966.85. This trade represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total value of $100,214.50. Following the completion of the sale, the vice president now directly owns 13,591 shares in the company, valued at approximately $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,994 shares of company stock valued at $729,430. Corporate insiders own 14.20% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.
Get Our Latest Stock Analysis on Kewaunee Scientific
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- Quiet Period Expirations Explained
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- CD Calculator: Certificate of Deposit Calculator
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Co. (NASDAQ:KEQU – Free Report).
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.